Skip to content

Evaluation of the “Champion” pilot project to standardize workflow for patients with diabetes and/or hypertension at the Palo Alto Medical Foundation

A quasi-experimental prospective evaluation of the CHAMPION chronic care model in a pilot clinic at PAMF

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN11341906
Enrollment
1008
Registered
2017-03-27
Start date
2013-09-13
Completion date
Unknown
Last updated
2017-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension and diabetes Signs and Symptoms Hypertension and diabetes

Interventions

This mixed-methods study incorporate direct observation of patient appointments, patient and health care team interviews, patient and physician surveys, and EHR data at baseline and then 6 months and

Sponsors

Palo Alto Medical Foundation Research Institute
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 18 years or older 2. Male and female 3. Diagnoses: hypertension only; diabetes only; hypertension & diabetes; hypertension & depression; diabetes & depression; hypertension & diabetes & depression

Exclusion criteria

Exclusion criteria: 1. Terminal illness 2. Residence in a long-term care facility 3. Severe hearing loss 4. Ongoing psychiatric care for bipolar or schizophrenia, or dementia

Design outcomes

Primary

MeasureTime frame
PCP experience with providing chronic care management using appointment observations, interviews, surveys and EHR data at baseline, 6 months and 12 months.

Secondary

MeasureTime frame
Patient experience with receiving chronic care management using appointment observations, interviews, surveys and EHR data at baseline, 6 months and 12 months.

Countries

United States of America

Contacts

Public ContactEllis Dillon
dillone@pamfri.org+1 (0)650 625 3876

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 27, 2026